Navigation Links
BioTrends Releases TreatmentTrends(TM): Nephrology and Renal Dietitians, Two Syndicated Reports Providing Continuing Insight into the Management of Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism
Date:10/27/2008

Ds report a high and growing influence in decisions regarding the use of Sensipar. Treatment prevalence with Sensipar in hemodialysis patients, according to both MDs and RDs has been lingering at around 30%. While Sensipar is often used second line to Vitamin D, it does seem to impact Vitamin D dose, with the majority of RDs reporting that patients on Sensipar tend to be on lower doses of Vitamin D.

In the renal anemia market, Nephrologists seem to be settling into the new treatment standards (e.g., lower target hemoglobin levels, lower levels for ESA initiation, holds, and dose reductions) and more than two-thirds do not anticipate making any additional changes to their use of ESAs in CKD or dialysis. While Amgen's Epogen continues to dominate the dialysis market, there did seem to be some brand shifting between Amgen's Aranesp and Ortho Biotech's Procrit in CKD. Nephrologists do not predict significant changes in ESA market share in CKD or dialysis in the near-term, but they do project that bundling will have an impact on ESA use most likely through shifts to subcutaneous dosing and less aggressive treatment of EPO hypo-responders. New ESAs in development could also shift market dynamics particularly if these products are able to meet what Nephrologists identified as the most desired attributes in a new ESA.

In terms of IV iron, American Regent's Venofer remains the market leader in both dialysis and CKD, however, office-based Nephrologists report significantly higher CKD share for Venofer and hospital-based Nephrologists report significantly higher CKD share for Watson's Ferrlecit. In the dialysis market, very little brand switching took place in the past year, although 60% of Nephrologists primarily affiliated with Fresenius units expect their use of Venofer to increase following the news that Fresenius will be marketing and distributing Venofer in dialysis units. Awareness of AMAG Pharmaceutical's Ferumoxytol continues to be low. Among those famil
'/>"/>

SOURCE BioTrends Research Group, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. BioTrends Research Group, Inc. Recognized as One of Philadelphias Fastest Growing Privately Held Companies
2. New Study by BioTrends Highlights Anemia Practice Patterns According to Anemia Managers in Both Dialysis Units and CKD Clinics/Offices
3. BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism
4. New Study by BioTrends Highlights Practice Management Shifts Among European Nephrologists
5. BioTrends Releases Two Publications - TreatmentTrends(TM): Nephrologists and TreatmentTrends(TM): Renal Dietitians - Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism
6. BioTrends Releases Fourth Annual Nephrology TreatmentTrends Publication Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism
7. T-System Releases The T SystemEV(R) 2.6.3, Featuring New Meds/Allergies Notification, Automated Charge Capture
8. BioWisdom Releases Text Analytics Version of OmniViz for Patent Specialists
9. Techne Corporation Releases Unaudited First Quarter Results for Fiscal Year 2009
10. Presidio Pay Advisors Releases Salary GPS Tool
11. Akaza Research Releases New Version of OpenClinica Electronic Data Capture (EDC) Software; Targets Industry Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... ... August 04, 2015 , ... On August 4, 2015, the White House will ... from across the United States to talk about their experiences with innovation and present ... to be among the attendees. , One of the day’s aims is to grow ...
(Date:8/3/2015)... 3, 2015 At the 11th ... waved the shortfall of Jude Liversage,s ... for the first time.      (Photo: ... ) The Selective Dorsal Rhizotomy (SDR) ... to carry out his wish to kick a ball ...
(Date:8/3/2015)...  Aethlon Medical, Inc. (Nasdaq: AEMD ), the ... diseases, today announced that it will host its First ... Thursday, August 13, 2015 at 4:30 p.m. Eastern Time. ... release of fiscal 2016 first quarter results.  A recorded ... hours after the call at the Investor Relations portion ...
(Date:8/3/2015)... ... August 03, 2015 , ... Sterlitech ... to its comprehensive line of analytical laboratory equipment. With optimized features, such as ... provide a chemically resistant and maintenance-free solution for a broad range of vacuum ...
Breaking Biology Technology:White House Invites uBiome CEO Jessica Richman to First-Ever Startup Demo Day 2Cerebral Palsy Operation by The Portland Hospital Allows a Boy to Stand Properly for the First Time 2Cerebral Palsy Operation by The Portland Hospital Allows a Boy to Stand Properly for the First Time 3Aethlon Medical To Host First Quarter Fiscal 2016 Investor Call on August 13, 2015 2Sterlitech Launches New Line of Vacuum Pumps 2
... — QBI Life Sciences said it ... and formed partnerships with UW-Madison and the University of ... a division of Quintessence Biosciences Inc. in Madison, will ... potentially harmful interactions between different drugs given to the ...
... a drop in net income to $13 million ... $21 million in the same quarter a year ... percent to $411 million, mostly from acquisitions. Modine ... industries, including fuel cells. , , Business ...
... and technology out there than ever before and according ... the right combination of the two will be key to ... take new roads because theres so much noise out there, ... spam, faxes, search engines and video on demand that demands ...
Cached Biology Technology:Exec focuses on blogs as business tool 2
(Date:7/7/2015)... , July 7, 2015  Based on ... Frost & Sullivan recognizes Credence ID, LLC with ... Entrepreneurial Company of the Year Award. Credence ID ... aid in its mission of offering enrollment and ... globally. As Credence ID was formed by experts ...
(Date:7/2/2015)... , June 25, 2015 ... announced the addition of the "Natural Language ... Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) ... their offering. The key vendors occupying ... HP, IBM Corporation, Microsoft Corporation, NetBase Solutions, SAS ...
(Date:7/2/2015)... , July 2, 2015 Fingerprint ... FPC1025, FPC1035, FPC1145 and FPC1155 from the distributor World Peace ... of FPC,s distributors in Asia . Deliveries ... The sensors will be used by smartphone manufacturers in ... is included in the communicated revenue guidance of approximately 2,200 ...
Breaking Biology News(10 mins):Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2
... an experimental vaccine targeting West Nile virus (WNV) opened ... Center in Bethesda, MD. The vaccine, which will be ... for human clinical studies by researchers at the National ... Center (VRC), and Vical Inc., San Diego, based on ...
... of New York University, in collaboration with Memorial Sloan ... change in shape in a carcinogen-damaged DNA site--in tumor ... in cigarette smoke. This finding may open new horizons ... The findings appear as the cover story in the ...
... favor, 34 against and 37 abstaining, with 36 absent, ... UN Member States to ban all forms of human ... human dignity and the protection of human life. , ... banning therapeutic cloning. The Declaration, negotiated by a Working ...
Cached Biology News:NIAID begins clinical trial of West Nile virus vaccine 2NIAID begins clinical trial of West Nile virus vaccine 3NYU and MSKCC research provides model for understanding chemically induced cancer initiation 2UN votes to ban human cloning 2
Rat whole blood (Sprague-Dawley, averaging 7-8 weeks of age, either sex) is collected at the time of slaughter and refrigerated within 6 hours, and processed and frozen within 24 hours. The serum is ...
... mutS and ES1301 mutS are mismatch repair ... these strains prevents repair of the newly ... mutation efficiencies and making them helpful in ... Sites II Mutagenesis Systems. Both ES1301 and ...
propidium iodide *1.0 mg/mL solution in water*...
SHEEP ANTI ECHIS OCCELATUS (VENOM)...
Biology Products: